Enhanced streptokinase-induced thrombolysis using heparin in a rabbit model

Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research
R L KoltsR D Sautter

Abstract

Heparin potentiation of clot lysis by streptokinase was studied in a rabbit model. Clot was initiated in the rabbit aorta with stasis and thrombin and allowed to naturally propagate proximally until stasis met flow. The clot was allowed to age for 1 h before assigning treatment. Fifteen rabbits (group I) were given streptokinase (10,000 IU/h) and 11 rabbits (group II) were given streptokinase (10,000 IU/h) plus sodium-heparin (120 IU/h). Thrombolytic therapy was continued for 5 h. Clot lysis averaged 30% in group I and 70% in group II. Ten of 11 rabbits in group II had more than 50% clot lysis, whereas only 4 of 15 in group I had this degree of lysis. One group II rabbit and four group I rabbits died prematurely; each was noted to have clot propagation at the time of death. While a trend for amelioration of hypofibrinogenemia was observed in the group receiving both streptokinase and heparin, this difference was not statistically significant. We conclude, in the animal model, that thrombolysis by a combination of heparin and streptokinase is more effective than streptokinase alone. Systemic effects are apparently no worse with the combination.

References

Jan 1, 1977·Haemostasis·F Markwardt, H P Klöcking
Apr 1, 1985·Seminars in Thrombosis and Hemostasis·J FareedH L Messmore
Mar 1, 1982·The Journal of Clinical Investigation·C KorningerD Collen

❮ Previous
Next ❯

Citations

May 28, 2016·Nature Reviews. Immunology·Yasmine Belkaid, Samira Tamoutounour
Mar 10, 2001·The Annals of Thoracic Surgery·R P Scott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.